However, Tamoxifen inhibited the interaction between menin and ER-alpha, and over-expression of menin caused tamoxifen resistance in a clinical study with 65 tamoxifen-treated ER-positive breast cancer samples [33]. Here, MEN1 is linked to breast cancer.